Dismiss
InnovationQ will be updated on Sunday, Oct. 22, from 10am ET - noon. You may experience brief service interruptions during that time.
Browse Prior Art Database

Method and System for Performing Non-Invasive Gastrointestinal Imaging

IP.com Disclosure Number: IPCOM000238662D
Publication Date: 2014-Sep-10
Document File: 2 page(s) / 67K

Publishing Venue

The IP.com Prior Art Database

Abstract

A method and system is disclosed for performing Gastrointestinal Imaging (GI) tests using a small pill-like device that is swallowed by a patient.

This text was extracted from a PDF file.
This is the abbreviated version, containing approximately 52% of the total text.

Page 01 of 2

Method and System for Performing Non -

-Invasive Gastrointestinal Imaging

Invasive Gastrointestinal Imaging

Disclosed is a method and system for performing Gastrointestinal Imaging (GI) tests using a small pill-like device that is swallowed by a patient. The method and system utilizes a smart capsule device with an increased functionality to be used in GI track investigations, such as, but not limited to, colonoscopies.

The method for performing Gastrointestinal Imaging (GI) tests is illustrated in the figure.

Figure

As illustrated in the figure, the smart capsule is swallowed and tracked throughout a patient's body using an RFID 3D localization technology. The RFID 3D location technology identifies the location of capsule within 1mm of its true location with improved image collection, transfer and real-time analysis. A 3D position estimation to determine the anatomical location of the smart capsule is utilized for detecting features of interest based on the images and the 3D position.

The 3D position of the smart capsule in relation to the patient 's anatomy is valuable because a location determination is important since different parts of the path require that the image analysis routines be tuned to detect different features . The location is also important for determining density based features , such as, more than two hematomas per foot. Finally, anomalies detected in different regions, for instance,

jejunum versus ileum, are clinically significant with regards to other expected symptoms, such as mal-absorption of folic acid versus vitamin B12.

An RFID reader then communicates the location of the smart capsule through a mobile phone application so that a doctor monitors the capsule 's movement and identifies the

1


Page 02 of 2

exact location of pathogen.

The smart capsule device incorporates a miniaturized camera for performing image collection and a wireless link for transmitting the images outside the patient's body . The...